Nuzenio

Stock Titan Cytomx

Stock Titan Cytomx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 13:21:14 GMTState Street Corporation (CTMX) reports 5.4% beneficial stake in CytomX Therapeutics - Stock Titan
Thu, 06 Aug 2026 20:15:00 GMTCytomX enrolls 113 patients; next colorectal cancer trial planned - Stock Titan
Wed, 05 Aug 2026 23:33:53 GMTCytomX Therapeutics, Inc. (CTMX) awards 450,000 options and 100,000 RSUs to CLO - Stock Titan
Wed, 05 Aug 2026 23:32:38 GMTCytomX Therapeutics, Inc. (CTMX) Chief Legal Officer files Form 3 insider report - Stock Titan
Mon, 03 Aug 2026 16:06:06 GMTBank of America (NYSE: BAC) discloses 7.0% ownership stake in CytomX (CTMX) - Stock Titan
Thu, 30 Jul 2026 07:00:00 GMTCytomX's second-quarter results call is set for Aug. 6 at 5 p.m. ET - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Cytomx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.